This title appears in the Scientific Report :
2021
Please use the identifier:
http://dx.doi.org/10.1007/s10548-021-00876-8 in citations.
Please use the identifier: http://hdl.handle.net/2128/30521 in citations.
Effects of Ketamine and Midazolam on Simultaneous EEG/fMRI Data During Working Memory Processes
Effects of Ketamine and Midazolam on Simultaneous EEG/fMRI Data During Working Memory Processes
Reliable measures of cognitive brain activity from functional neuroimaging techniques may provide early indications of efficacy in clinical trials. Functional magnetic resonance imaging and electroencephalography provide complementary spatiotemporal information and simultaneous recording of these tw...
Saved in:
Personal Name(s): | Forsyth, Anna E. M. (Corresponding author) |
---|---|
McMillan, Rebecca / Dukart, Juergen / Hipp, Jörg F. / Muthukumaraswamy, Suresh D. | |
Contributing Institute: |
Gehirn & Verhalten; INM-7 |
Published in: | Brain topography, 34 (2021) 6, S. 863 - 880 |
Imprint: |
Dordrecht [u.a.]
Springer Science + Business Media B.V
2021
|
DOI: |
10.1007/s10548-021-00876-8 |
Document Type: |
Journal Article |
Research Program: |
Multilevel Brain Organization and Variability |
Link: |
Restricted Published on 2021-10-13. Available in OpenAccess from 2022-10-13. |
Publikationsportal JuSER |
Please use the identifier: http://hdl.handle.net/2128/30521 in citations.
Reliable measures of cognitive brain activity from functional neuroimaging techniques may provide early indications of efficacy in clinical trials. Functional magnetic resonance imaging and electroencephalography provide complementary spatiotemporal information and simultaneous recording of these two modalities can remove inter-session drug response and environment variability. We sought to assess the effects of ketamine and midazolam on simultaneous electrophysiological and hemodynamic recordings during working memory (WM) processes. Thirty participants were included in a placebo-controlled, three-way crossover design with ketamine and midazolam. Compared to placebo, ketamine administration attenuated theta power increases and alpha power decreases and midazolam attenuated low beta band decreases to increasing WM load. Additionally, ketamine caused larger blood-oxygen-dependent (BOLD) signal increases in the supplementary motor area and angular gyrus, and weaker deactivations of the default mode network (DMN), whereas no difference was found between midazolam and placebo. Ketamine administration caused positive temporal correlations between frontal-midline theta (fm-theta) power and the BOLD signal to disappear and attenuated negative correlations. However, the relationship between fm-theta and the BOLD signal from DMN areas was maintained in some participants during ketamine administration, as increasing theta strength was associated with stronger BOLD signal reductions in these areas. The presence of, and ability to manipulate, both positive and negative associations between the BOLD signal and fm-theta suggest the presence of multiple fm-theta components involved in WM processes, with ketamine administration disrupting one or more of these theta-linked WM strategies. |